Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus

Vaccine

Volumn 29, Issue 29-30, 2011, Pages 4657-4662

  Xue, Wenzhi ^a   Mattick, Debra ^a   Smith, Linda ^a  

^a Intervet/Schering Plough Animal Health   (United States)

Author keywords

Bovine viral diarrhea virus; BVDV 1a; BVDV 1b; Cross protection; Modified live virus vaccine; Persistent infection; PI protection

Indexed keywords

BOVINE DIARRHEA VIRUS VACCINE TYPE 1A; BOVINE DIARRHEA VIRUS VACCINE TYPE 2; LIVE VACCINE; PLACEBO; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BOVINE DIARRHEA VIRUS; BOVINE HERPES VIRUS; BOVINE RESPIRATORY SYNCYTIAL PNEUMOVIRUS; BOVINE RESPIRATORY SYNCYTIAL VIRUS INFECTION; BOVINE VIRAL DIARRHEA; BOVINE VIRAL DIARRHEA VIRUS TYPE 1B; CATTLE FARMING; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FETUS; GESTATIONAL AGE; INFECTION PREVENTION; INFECTIOUS BOVINE RHINOTRACHEITIS; INTESTINE; INTRAUTERINE INFECTION; KIDNEY PARENCHYMA; LUNG PARENCHYMA; NONHUMAN; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS INFECTION; PERSISTENT INFECTION; PNEUMOVIRINAE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SPLEEN; THYMUS; VACCINATION; VIREMIA; VIRUS ISOLATION; VIRUS STRAIN;

EID: 79960630919     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.129     Document Type: Article

References (38)

1. Duffell SJ, Harkness JW. Bovine viral diarrhoea-mucosal disease infection in cattle. Vet Rec 1985;117:240-5.
2. Houe H. Epidemiological features and economical importance of bovine virus diarrhea virus (BVDV) infections. Vet Microbiol 1999;64:89-107.
3. Baker JC. Bovine viral diarrhea virus: a review. J Am Vet Med Assoc 1987;190:1449-58.
4. Baker JC. The clinical manifestations of bovine viral diarrhea infection. Vet Clin North Am Food Anim Prac 1995;11:425-45.
5. Bolin SR. Control of bovine viral diarrhea infection by use of vaccination. Vet Clin North Am 1995;11:616-25.
6. Radostits OM, Littlejohns IR. New concepts in the pathogenesis, diagnosis and control of diseases caused by the bovine viral diarrhea virus. Can Vet J 1988;29:513-28.
7. Thiel HJ, Collett MS, Gould EA. Family Flaviviridae. In: Maniloff MAJ, Fauquet Mayo CM, editors. Eighth report of the International Committee on Taxonomy of Viruses. San Diego, CA: Elsevier Academic Press; 2005. p. 981-98.
8. Vilcek S, Paton DJ, Durkovic B, Strojny L, Ibata G, Moussa A, et al. Bovine viral diarrhoea virus genotype 1 can be separated into at least eleven genetic groups. Arch Virol 2001;146:99-115.
9. Bachofen C, Stalder H, Braun U, Hilbe M, Ehrensperger F, Peterhans E, et al. Coexistence of genetically and antigenically diverse bovine viral diarrhoea viruses in an endemic situation. Vet Microbiol 2008;131:93-102.
10. Ridpath JF, Fulton RW, Kirkland PD, Neil JD. Prevalence and antigenic differences observed between bovine viral diarrhea virus subgenotypes isolated from cattle in Australia and feedlots in the southwestern United States. J Vet Diagn Invest 2010;22:184-91.
11. Fulton RW, Ridpath JF, Saliki JT, Briggs RE, Confer AW, Burge LJ, et al. Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease. Can J Vet Res 2002;66:181-90.
12. Stahl K, Benito F, Felmer R, Zuniga J, Reinhardt G, Rivera H, et al. Genetic diversity of bovine viral diarrhoea virus (BVDV) from Peru and Chile. Pesq Vet Bras 2009;29:41-4.
13. Ridpath JF, Lovell G, Neill JD, Hairgrove TB, Velayudhan B, Mock R. Change in predominance of bovine viral diarrhea virus subgenotypes among samples submitted to a diagnostic laboratory over a 20-year time span. J Vet Diagn Invest 2011;23:185-93.
14. Xue W, Mattick D, Smith L, Umbaugh J, Trigo E. Vaccination with a modifiedlive bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains. Vaccine 2010;29:70-6.
15. Brock KV, Grooms DL, Givens MD. Reproductive disease and persistently infection. In: Goyal SM, Ridpath JF, editors. Bovine viral diarrhea virus: diagnosis, management, and control. Ames: Blackwell Publishing; 2005. p. 146-56.
16. Muñoz-Zanzi CA, Hietala SK, Thurmond MC, Johnson WO. Quantification, risk factors, and health impact of natural congenital infection with bovine viral diarrhea virus in diary calves. Am J Vet Res 2003;64:358-65.
17. McClurkin AW, Littledike ET, Cutlip RC. Production of cattle immunotolerant to bovine viral diarrhea virus (BVDV). Can J Comp Med 1984;48:156-61.
18. Houe H, Baker JC, Maes RK, Wuryastuti H, Wasito R, Ruegg PL, et al. Prevalence of cattle persistently infected with bovine viral diarrhea virus in 20 dairy herds in two counties in central Michigan and comparison of prevalence of antibodypositive cattle among herds with different infection and vaccination status. J Vet Diagn Invest 1995;7:321-6.
19. Wittum TE, Grotelueschen DM, Brock KV, Kvasnicka WG, Floyd JG, Kelling CL, et al. Persistent bovine viral diarrhoea virus infection in US beef herds. Prev Vet Med 2001;49:83-94.
20. Loneragan GH, Thomson DU, Montgomery DL, Mason GL, Larson RL. Prevalence, outcome, and health consequences associated with persistent infection with bovine viral diarrhea virus in feedlot cattle. J Am Vet Med Assoc 2005;226:595-601.
21. Corteses VS, Grooms DL, Ellis J. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modifiedlive virus vaccine. Am J Vet Res 1998;59:1409-13.
22. Brock KV, Corteses VS. Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine. Vet Ther 2001;2:354-60.
23. Kovacs F, Magyar T, Rinehart C, Elbers K, Schlesinger K, Ohnesorge WC. The live attenuated bovine viral diarrhea virus components of multi-valent vaccine confer protection against fetal infection. Vet Microbiol 2003;96:117-31.
24. Frey HR, Eicken K, Grummer B, Kenklies S, Oguzoglu TC, Moennig V. Foetal protection against bovine virus diarrhoea virus after two-step vaccination. J Vet Med B 2002;49:489-93.
25. Dean HJ, Hunsaker D, Bailey OD, Wasmoen T. Prevention of persistently infection on calves by vaccination of dams with noncytopathic type-1 modified-live bovine viral diarrhea virus prior to breeding. Am J Vet Res 2003;64:530-7.
26. Ficken MD, Ellsworth MA, Tucher CM, Cortese VS. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or type 1 and type 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation. J Am Vet Med Assoc 2006;228:1559-64.
27. Schnackel JA, Van Campen H, van Olphen A. Modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine provides protection against fetal infection after challenge with either type 1b or type 2 BVDV. Bovine Pract 2007;41:1-9.
28. Grooms DL, Bolin SR, Coe PH, Borges RJ, Coutu CE. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle. Am J Vet Res 2007;68:1417-22.
29. Xue W, Ellis J, Mattick D, Smith L, Brady R, Trigo E. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves. Vaccine 2010;28:3784-92.
30. Xue W, Mattick D, Smith L, Maxwell J. Fetal protection against bovine viral diarrhea virus types 1 and 2 after use of a modified-live virus vaccine. Can J Vet Res 2009;73:292-7.
31. Van Campen H. Epidemiology and control of BVD in the U.S. Vet Microbiol 2010;142:94-8.
32. Liebler-Tenorio EM, Ridpath JF, Neill JD. Distribution of viral antigen and development of lessons after experimental infection of calves a BVDV 2 strain of low virulence. J Vet Diagn Invest 2003;15:221-32.
33. Pecora A, Malacari DA, Aguirreburualde MSP, Zamit AL, Santos MJD, Combessies G, et al. Genetic and antigenic variability of bovine viral diarrhea virus in Argentinean field isolates. In: Proceeding of XXVI World Buiatrics Congress. 2010. p. 165.
34. Swasdipan S, McGowan M, Phillips N, Bielefeld-Ohmann H. Pathogenesis of transplacental virus infection: pestivirus replication in the placenta and fetus following respiratory infection. Microb Pathog 2002;32:49-60.
35. Fredriksen B, Press CM, Loken T, Odegaard SA. Distribution of viral antigen in uterus, placenta and foetus of cattle persistently infected with bovine virus diarrhoea virus. Vet Microbiol 1999;64:109-22.
36. Liess B, Orban S, Frey HR, Trautwein G. Consequences of the transplacental transmission of BVD virus to cattle fetuses. Dtsch Tierarztl Wochenschr 1987;94:585-7.
37. Harding MJ, Cao X, Shams H, Johnson AF, Vassiles VB, Wheeler DW, et al. Role of bovine viral diarrhea virus biotype in the establishment of fetal infection. Am J Vet Res 2002;63:1455-63.
38. Brock KV, Chase CCL. Development of a fetal challenge method for the evaluation of bovine viral diarrhea virus vaccines. Vet Microbiol 2000;77:209-14.